Production (Stage)
D
MediPharm Labs Corp. MEDIF
$0.055 -$0.0039-6.62% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -269.70K -1.23M -2.03M -1.89M -2.68M
Total Depreciation and Amortization 296.10K 400.80K 379.80K 534.20K 586.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 241.80K -516.50K 525.00K 600.00K 568.90K
Change in Net Operating Assets -2.37M 586.50K 643.70K -420.20K 391.60K
Cash from Operations -2.10M -762.20K -485.40K -1.17M -1.13M
Capital Expenditure -29.30K -31.40K -24.20K -40.90K -15.60K
Sale of Property, Plant, and Equipment -- 0.00 -- 15.30K 405.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -29.30K -31.40K -24.20K -25.60K 389.40K
Total Debt Issued -- 0.00 50.00K 749.00K --
Total Debt Repaid -265.00K -337.00K -2.29M -153.00K -269.00K
Issuance of Common Stock -- 14.00K -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 56.00K 79.00K 20.00K 89.00K 203.00K
Cash from Financing -145.60K -174.30K -1.63M 500.60K -49.00K
Foreign Exchange rate Adjustments 11.10K -33.60K 13.20K 15.30K 8.90K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -2.26M -1.00M -2.13M -683.30K -782.50K